Christiaans MH - Search Results

1

The Maastricht Transplant Center: clinical setting and epitope searches in HLA class II molecules: does the structural localization of a polymorphic site contribute to its immunogenicity?

Schellekens J, Vanderlocht J, Groeneweg M, Voorter CE, Wieten L, Gelens MA, van Duijnhoven EM, van Heurn LW, Christiaans MH, Tilanus MG. Schellekens J, et al. Among authors: christiaans mh. Transpl Immunol. 2014 Oct;31(4):213-8. doi: 10.1016/j.trim.2014.09.002. Epub 2014 Sep 21. Transpl Immunol. 2014. PMID: 25240735 Review.

2

Risk factors for cytomegalovirus infection and disease in renal transplant recipients: HLA-DR7 and triple therapy.

Kraat YJ, Christiaans MH, Nieman FH, van den Berg-Loonen PM, van Hooff JP, Bruggeman CA. Kraat YJ, et al. Among authors: christiaans mh. Transpl Int. 1994 Aug;7(5):362-7. doi: 10.1007/BF00336713. Transpl Int. 1994. PMID: 7993574

3

Tacrolimus dosing requirements in diabetic and nondiabetic patients calculated from pretransplantation data.

van Duijnhoven E, Christiaans M, Schäfer A, Undre N, van Hooff J. van Duijnhoven E, et al. Transplant Proc. 1998 Jun;30(4):1266-7. doi: 10.1016/s0041-1345(98)00236-x. Transplant Proc. 1998. PMID: 9636514 No abstract available.

4

The effect of breakfast on the oral bioavailability of tacrolimus in diabetic and nondiabetic patients before transplantation.

van Duijnhoven E, Christiaans M, Undre N, Stevenson P, van Hooff J. van Duijnhoven E, et al. Transplant Proc. 1998 Jun;30(4):1268-70. doi: 10.1016/s0041-1345(98)00237-1. Transplant Proc. 1998. PMID: 9636515 No abstract available.

5

Effect of breakfast on the oral bioavailability of tacrolimus and changes in pharmacokinetics at different times posttransplant in renal transplant recipients.

Christiaans M, van Duijnhoven E, Beysens T, Undre N, Schäfer A, van Hooff J. Christiaans M, et al. Transplant Proc. 1998 Jun;30(4):1271-3. doi: 10.1016/s0041-1345(98)00238-3. Transplant Proc. 1998. PMID: 9636516 No abstract available.

6

HLA-DR matched transfusions: development of donor-specific T- and B-cell antibodies and renal allograft outcome.

Christiaans MH, van Hooff JP, Nieman F, van den Berg-Loonen EM. Christiaans MH, et al. Transplantation. 1999 Apr 15;67(7):1029-35. doi: 10.1097/00007890-199904150-00016. Transplantation. 1999. PMID: 10221489

7

Tacrolimus and glucose metabolism.

van Hooff JP, van Duijnhoven EM, Christiaans MH. van Hooff JP, et al. Among authors: christiaans mh. Transplant Proc. 1999 Nov;31(7A):49S-50S. doi: 10.1016/s0041-1345(99)00795-2. Transplant Proc. 1999. PMID: 10576044 Clinical Trial. No abstract available.

8

Dosing and management guidelines for tacrolimus in renal transplant patients.

van Hooff JP, Boots JM, van Duijnhoven EM, Christiaans MH. van Hooff JP, et al. Among authors: christiaans mh. Transplant Proc. 1999 Nov;31(7A):54S-57S. doi: 10.1016/s0041-1345(99)00796-4. Transplant Proc. 1999. PMID: 10576046 No abstract available.

9

Glucose metabolism in the first 3 years after renal transplantation in patients receiving tacrolimus versus cyclosporine-based immunosuppression.

van Duijnhoven EM, Christiaans MHL, Boots JMM, Nieman FHM, Wolffenbuttel BHR, van Hooff JP. van Duijnhoven EM, et al. J Am Soc Nephrol. 2002 Jan;13(1):213-220. doi: 10.1681/ASN.V131213. J Am Soc Nephrol. 2002. PMID: 11752040 Clinical Trial.

10

Glucose metabolism in renal transplant recipients on tacrolimus: the effect of steroid withdrawal and tacrolimus trough level reduction.

Boots JMM, van Duijnhoven EM, Christiaans MHL, Wolffenbuttel BHR, van Hooff JP. Boots JMM, et al. J Am Soc Nephrol. 2002 Jan;13(1):221-227. doi: 10.1681/ASN.V131221. J Am Soc Nephrol. 2002. PMID: 11752041

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

177 results

Search Page

Filters